Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RGC
DateTimeSourceHeadlineSymbolCompany
20/06/202414:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RGCRegencell Bioscience Holdings Ltd
02/01/202411:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RGCRegencell Bioscience Holdings Ltd
15/12/202311:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RGCRegencell Bioscience Holdings Ltd
27/10/202321:15Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:RGCRegencell Bioscience Holdings Ltd
15/06/202321:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
05/06/202311:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
17/03/202310:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
28/02/202314:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
04/01/202313:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
22/12/202212:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
31/10/202220:18Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/09/202214:18Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/09/202214:15Business WireRegencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy TrialNASDAQ:RGCRegencell Bioscience Holdings Ltd
26/07/202213:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
07/06/202216:37ValueWalkGame-Stop Or Game-On? RGC Has It All And Twice MoreNASDAQ:RGCRegencell Bioscience Holdings Ltd
02/06/202221:17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
18/05/202213:05Business WireRegencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment PeriodNASDAQ:RGCRegencell Bioscience Holdings Ltd
18/05/202212:58Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
16/05/202213:56Business WireRegencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEONASDAQ:RGCRegencell Bioscience Holdings Ltd
16/05/202212:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
16/05/202212:00Business WireRegencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEONASDAQ:RGCRegencell Bioscience Holdings Ltd
16/05/202211:51Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
26/04/202213:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
04/04/202212:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
30/12/202121:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
15/12/202114:49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RGCRegencell Bioscience Holdings Ltd
13/12/202113:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
17/11/202122:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
29/10/202113:32Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:RGCRegencell Bioscience Holdings Ltd
07/09/202121:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
 Showing the most relevant articles for your search:NASDAQ:RGC

Your Recent History